Addus HomeCare Co. (NASDAQ:ADUS) CEO Sells $1,539,500.00 in Stock

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 12,500 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Addus HomeCare Price Performance

ADUS stock traded up $1.46 during midday trading on Tuesday, hitting $124.41. The company’s stock had a trading volume of 130,280 shares, compared to its average volume of 131,677. The company’s fifty day moving average price is $128.07 and its 200 day moving average price is $123.41. Addus HomeCare Co. has a twelve month low of $85.43 and a twelve month high of $136.12. The stock has a market capitalization of $2.26 billion, a P/E ratio of 28.32, a PEG ratio of 2.17 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.03 EPS. Equities analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.63.

Hedge Funds Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the business. Quarry LP acquired a new position in shares of Addus HomeCare during the 3rd quarter worth approximately $28,000. UMB Bank n.a. grew its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares in the last quarter. Quest Partners LLC bought a new position in Addus HomeCare during the 2nd quarter worth $31,000. Farther Finance Advisors LLC raised its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares in the last quarter. Finally, Innealta Capital LLC bought a new stake in shares of Addus HomeCare during the 2nd quarter valued at $44,000. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.